MeSH D000163 - acquired immunodeficiency syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Ritonavir | Norvir | 1996-03-01 | |||
| AbbVie | Lopinavir, Ritonavir | Kaletra | 2000-09-15 | $291 M | Q2/19-Q1/20 | |
| Ritonavir | Norvir | 1996-03-01 | $165 M | Q1/12-Q1/13 | ||
| Ritonavir, Ombitasvir, Paritaprevir | Technivie | 2024-08-25 | 2015-07-24 | |||
| Ritonavir, Dasabuvir, Ombitasvir, Paritaprevir | Viekira | 2024-08-25 | 2014-12-19 | $16 M | Q2/19-Q1/20 | |
| Ritonavir, Ombitasvir, Paritaprevir | Viekirax | 2015-01-14 | ||||
| Agouron Pharmaceuticals | Nelfinavir | Viracept | 1997-03-14 | |||
| Alvogen | Nevirapine | Nevirapine | 2015-07-10 | |||
| American Regent | Zidovudine | Zidovudine | 2010-05-06 | |||
| Amneal Pharmaceuticals | Atazanavir | Atazanavir | 2020-06-01 | |||
| Ritonavir | Ritonavir | 2018-09-17 | ||||
| Darunavir | Darunavir | 2023-12-08 | ||||
| Annora Pharma | Lamivudine | Lamivudine | 2019-03-21 | |||
| Darunavir | Darunavir | 2025-01-21 | ||||
| Apotex | Abacavir | Abacavir | 2012-12-17 | |||
| Lamivudine | Lamivudine | 2011-12-02 | ||||
| Nevirapine | Nevirapine | 2012-05-22 | ||||
| Aurobindo Pharma | Abacavir | Abacavir | 2012-12-17 | |||
| Lamivudine, Abacavir | Abacavir Lamivudine | 2018-11-15 | ||||
| Atazanavir | Atazanavir | 2018-06-25 | ||||
| Didanosine | Didanosine | 2012-08-14 | ||||
| Efavirenz | Efavirenz | 2018-09-21 | ||||
| Emtricitabine, Tenofovir disoproxil, Efavirenz | Efavirenz, Emtricitabine, Tenofovir Disoproxil | 2018-09-04 | ||||
| Tenofovir disoproxil, Efavirenz, Lamivudine | Efavirenz, Lamivudine Tenofovir Disoproxil | 2018-08-15 | ||||
| Lamivudine | Lamivudine | 2016-11-21 | ||||
| Tenofovir disoproxil, Lamivudine | Lamivudine Tenofovir Disoproxil | 2018-05-15 | ||||
| Lamivudine, Zidovudine | Lamivudine Zidovudine | 2017-05-05 | ||||
| Nevirapine | Nevirapine | 2012-05-22 | ||||
| Ritonavir | Ritonavir | 2018-09-17 | ||||
| Stavudine | Stavudine | 2008-12-29 | ||||
| Zidovudine | Zidovudine | 2005-09-19 | ||||
| Darunavir | Darunavir | 2023-11-28 | ||||
| Barr Pharmaceuticals | Didanosine | Didanosine | 2004-12-03 |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
73%16/22
Phase 2
46%18/39
Phase 3
73%36/49
Approved: 21Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use